Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naïve HIV-2-infected patients: The ACHIEV2E collaboration study group

  1. Benard, A.
  2. Van Sighem, A.
  3. Taieb, A.
  4. Valadas, E.
  5. Ruelle, J.
  6. Soriano, V.
  7. Calmy, A.
  8. Balotta, C.
  9. Damond, F.
  10. Brun-Vezinet, F.
  11. Chene, G.
  12. Matheron, S.
Revue:
Clinical Infectious Diseases

ISSN: 1058-4838,  1537-6591

Année de publication: 2011

Volumen: 52

Número: 10

Pages: 1257-1266

Type: Article

DOI: 10.1093/CID/CIR123 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus